Person

Richard Sulpizio

Director, ResMed

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$14.5M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 30, 2018RMDSale28,403$102.78$2.9M
Aug 9, 2017RMDSale24,390$73.85$1.8M
Jun 22, 2017RMDSale65,887$77.82$5.1M
Aug 10, 2016RMDSale36,000$70.15$2.5M
Feb 26, 2016RMDSale36,000$57.88$2.1M

SEC reporting-owner ID (CIK) 1191329 · all filings on EDGAR